A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma

Da Shi; Qinghua Qu; Qimeng Chang; Yilin Wang; Yaping Gui; Dong Dong

doi:10.18632/oncotarget.17506

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma

Da Shi, Qinghua Qu, Qimeng Chang, Yilin Wang, Yaping Gui and Dong Dong _

PDF | HTML | How to cite

Oncotarget. 2017; 8:58699-58708. https://doi.org/10.18632/oncotarget.17506

Metrics: PDF 3587 views | HTML 4455 views | ?

Abstract

Da Shi1,*, Qinghua Qu2,*, Qimeng Chang4, Yilin Wang5, Yaping Gui3 and Dong Dong1

1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China

2Department of Urology, Pudong People’s Hospital, Shanghai, China

3Department of Urology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China

4Department of General Surgery, Minhang Hospital, Fudan University, Shanghai, China

5Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

*These authors have contributed equally to this work

Correspondence to:

Dong Dong, email: [email protected]

Yaping Gui, email: [email protected]

Keywords: long non-coding RNA, clear cell renal cell carcinoma, prognosis

Received: December 09, 2016 Accepted: March 22, 2017 Published: April 28, 2017

ABSTRACT

Recent works have reported that long non-coding RNAs (lncRNAs) play critical roles in tumorigenesis and prognosis of cancers, suggesting the potential utility of lncRNAs as cancer prognostic markers. However, lncRNA signatures in predicting the survival of patients with clear cell renal cell carcinoma (ccRCC) remain unknown. In this study, we attempted to identify lncRNA signatures and their prognostic values in ccRCC. Using lncRNA expression profiling data in 440 ccRCC tumors from The Cancer Genome Atlas (TCGA) data, a five-lncRNA signature (AC069513.4, AC003092.1, CTC-205M6.2, RP11-507K2.3, U91328.21) has been identified to be significantly associated with ccRCC patients’ overall survival in both training set and testing set. Based on the lncRNA signature, ccRCC patients could be divided into high-risk and low-risk group with significantly different survival rate. Further multivariable Cox regression analysis suggested that the prognostic value of this signature was independent of clinical factors. Functional enrichment analyses showed the potential functional roles of the five prognostic lncRNAs in ccRCC oncogenesis. These results indicated that this five-lncRNA signature could be used as an independent prognostic biomarker in the prediction of ccRCC patients’ survival.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17506

Publication Alerts

Research Papers:

A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma

Abstract